Basse T, Schwarzbach C, von der Schulenburg J
Eur J Health Econ. 2022; 24(5):803-816.
PMID: 36018442
PMC: 10198850.
DOI: 10.1007/s10198-022-01510-5.
Schlander M, Hernandez-Villafuerte K, Cheng C, Mestre-Ferrandiz J, Baumann M
Pharmacoeconomics. 2021; 39(11):1243-1269.
PMID: 34368939
PMC: 8516790.
DOI: 10.1007/s40273-021-01065-y.
Wouters O, Mckee M, Luyten J
JAMA. 2020; 323(9):844-853.
PMID: 32125404
PMC: 7054832.
DOI: 10.1001/jama.2020.1166.
Deming D
Philosophia (Ramat Gan). 2018; 44(4):1319-1331.
PMID: 30158736
PMC: 6099700.
DOI: 10.1007/s11406-016-9779-7.
Cousin M, Greenberg A, Koep T, Angius D, Yaszemski M, Spinner R
Tissue Eng Part B Rev. 2016; 22(6):430-437.
PMID: 27470313
PMC: 5124733.
DOI: 10.1089/ten.TEB.2016.0060.
Cancer care burden: aiming at the Achilles heel.
Ahmed S, Shahid R, Gesy K
Curr Oncol. 2015; 22(3):e134-8.
PMID: 26089722
PMC: 4462533.
DOI: 10.3747/co.22.2252.
The Expected Net Present Value of Developing Weight Management Drugs in the Context of Drug Safety Litigation.
Chawla A, Carls G, Deng E, Tuttle E
Pharmacoeconomics. 2015; 33(7):749-63.
PMID: 26054325
DOI: 10.1007/s40273-015-0300-0.
Situation analysis of R & d activities: an empirical study in Iranian pharmaceutical companies.
Rasekh H, Mehralian G, Vatankhah-Mohammadabadi A
Iran J Pharm Res. 2013; 11(4):1013-25.
PMID: 24250532
PMC: 3813171.
Drug design and discovery: translational biomedical science varies among countries.
Weaver I, Weaver D
Clin Transl Sci. 2013; 6(5):409-13.
PMID: 24127932
PMC: 5350896.
DOI: 10.1111/cts.12058.
Determining quantitative targets for public funding of tuberculosis research and development.
Walwyn D
Health Res Policy Syst. 2013; 11(1):10.
PMID: 23496963
PMC: 3599983.
DOI: 10.1186/1478-4505-11-10.
An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) project.
Meurer W, Lewis R, Tagle D, Fetters M, Legocki L, Berry S
Ann Emerg Med. 2012; 60(4):451-7.
PMID: 22424650
PMC: 3557826.
DOI: 10.1016/j.annemergmed.2012.01.020.
Cost effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer.
Gold H, Hall M, Blinder V, Schackman B
Cancer. 2009; 115(17):3858-67.
PMID: 19517472
PMC: 2853177.
DOI: 10.1002/cncr.24428.
Fact or fiction: the need for independent pharmaceutical policy research.
Keyhani S, Federman A
J Gen Intern Med. 2009; 24(5):692-4.
PMID: 19343457
PMC: 2669879.
DOI: 10.1007/s11606-009-0964-2.
Measuring US pharmaceutical industry R&D spending.
Golec J, Vernon J
Pharmacoeconomics. 2008; 26(12):1005-17.
PMID: 19014202
DOI: 10.2165/0019053-200826120-00004.
Are drugs too expensive in Canada? Yes.
Lexchin J
Can Fam Physician. 2006; 52:573-6, 578-81.
PMID: 16739821
PMC: 1531713.
